Publication | Closed Access

EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization

Surgical OncologyHepatologyMedicineIndependent Prognostic FactorsLiver DiseaseLiver CancerMrecist ResponsesTransarterial EmbolizationOncologyRadiation OncologyHepatocellular CarcinomaRadiologyHealth Sciences